Thus, we speculate that IGFBP2 might undergo various modifications during sarcopenia pathogenesis, which may alter the targeted antigenic epitope for recognition and affect the affinity of antigen binding, ultimately resulting in detection discrepancies. The gene discussed is IGFBP2; the disease is sarcopenia.